The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors. Read more about The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors.
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia. Read more about Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Read more about Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).
Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review. Read more about Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review.
Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Read more about Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Read more about Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study. Read more about Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Read more about No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
The ASPHO 2019 distinguished career award goes to Dr. Elliott P. Vichinsky. Read more about The ASPHO 2019 distinguished career award goes to Dr. Elliott P. Vichinsky.
Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia. Read more about Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia.
